Cargando…

IS BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG USE IN PATIENTS WITH AUTOIMMUNE DISEASES A RISK FACTOR FOR SEVERE SARS-COV-2 INFECTION?

Detalles Bibliográficos
Autores principales:	WAQAR, HAFIZA HAREEM, MAHMOOD, FATIMA, NAUTIYAL, AMIT
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:	Lung Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548847/ http://dx.doi.org/10.1016/j.chest.2022.08.1547

Ejemplares similares

ASSESSMENT OF RESPIRATORY FUNCTION IN PATIENTS AFTER SARS-COV-2 LUNG DISEASE
por: PINI, LAURA, et al.
Publicado: (2021)

DRUG-INDUCED PNEUMONITIS IN THE SETTING OF SARS-COV-2 INFECTION
por: UDEH, UBA C, et al.
Publicado: (2022)

SEVERE COVID-19 ASSOCIATED WITH ADVANCED FORMS OF PULMONARY TB DISEASE IN AN ENDEMIC AREA OF ROMANIA
por: ARGHIR, I., et al.
Publicado: (2022)

SEATED-IMMOBILITY THROMBOEMBOLISM SYNDROME COMPLICATING CORONAVIRUS DISEASE 2019 OUTBREAK QUARANTINE
por: Ali, Abdulla, et al.
Publicado: (2020)

Immunodeficiency and autoimmunity during biological disease-modifying antirheumatic drug therapy
por: Czekalska, Anna, et al.
Publicado: (2019)

SPONTANEOUS PNEUMOTHORAX AND SPONTANEOUS PNEUMOMEDIASTINUM IN NON-INTUBATED PATIENTS IN THE SETTING OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
por: George, Blessen, et al.
Publicado: (2020)

A CASE OF RIGHT LOWER LOBECTOMY DUE TO A SPONTANEOUS HEMOPNEUMOTHORAX WHILE ON ECMO IN A PATIENT WITH COVID-19
por: WONG, FATIMA, et al.
Publicado: (2021)

THE UTILITY OF EARLY HIGH FLOW NASAL OXYGEN THERAPY (FROM ER TO DISCHARGE AND HOME) IN PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: SPACONE, ANTONELLA, et al.
Publicado: (2021)

CALM BEFORE THE STORM: COVID-19 AND CYTOKINE STORM SYNDROME
por: Chahal, Japjot, et al.
Publicado: (2020)

WHAT IS THE CULPRIT OF CAUSING PNEUMATOCELE: COVID-19 INFECTION OR THE POSITIVE END-EXPIRATORY PRESSURE
por: ALKHATATNEH, AHMAD, et al.
Publicado: (2021)

TRANSFUSION-RELATED ACUTE LUNG INJURY ASSOCIATED WITH BANLAMIVIMAB INFUSION
por: DUMOVICH, JENNA, et al.
Publicado: (2021)

CHALLENGES IN DIAGNOSIS AND MANAGEMENT OF EVALI IN THE COVID-19 ERA: A SYSTEMATIC REVIEW
por: AYAZ AHMED, MUBASHIR, et al.
Publicado: (2021)

HISTOPATHOLOGY CONSISTENT WITH COVID-19 INFECTION DESPITE MULTIPLE NEGATIVE COVID-19 PCR TESTS IN A MALE WITH ARDS
por: NHI NGUYEN, BAO, et al.
Publicado: (2021)

"SINGULTUS": AN ATYPICAL PRESENTATION OF COVID-19 INFECTION
por: ROMAN-VELEZ, NESHMA, et al.
Publicado: (2021)

EFFECT OF CORTICOSTEROIDS ON NOSOCOMIAL INFECTIONS IN PATIENTS WITH COVID-19, A SYSTEMATIC REVIEW OF RANDOMIZED CLINICAL TRIALS
por: SHARAYAH, AHMAD, et al.
Publicado: (2021)

A CASE OF HAFNIA ALVEI AND CANDIDA AURIS BLOODSTREAM INFECTION IN PATIENTS WITH COVID-19
por: GONUGUNTLA, VARUN TEJ, et al.
Publicado: (2021)

VIRLAZA IMPROVES CARDIOPULMONARY RECOVERY OF POST-COVID-19 PATIENT: A CASE REPORT
por: FERREIRA, RENILSON, et al.
Publicado: (2021)

STUDY OF LUNG BIOPSIES BY TRANSMISSION ELECTRON MICROSCOPY IN DECEASED PATIENTS WITH COVID-19
por: VIDAL GONZáLEZ, ÁNXELA, et al.
Publicado: (2021)

PULSE-DOSE STEROIDS FOR USE IN PULMONARY FIBROSIS RELATED TO COVID-19 INFECTION
por: BRADY, JAMES, et al.
Publicado: (2021)

MASSIVE HEMOPTYSIS POST COVID-19 INFECTION IN THE SETTING OF UNILATERAL PULMONARY ARTERY AGENESIS
por: MAITZ, THERESA, et al.
Publicado: (2021)

ASSESSMENT OF PULMONARY FUNCTION OUTCOMES IN PATIENTS WITH COVID-19 SIX-WEEKS POST HOSPITAL DISCHARGE: A SINGLE-CENTER OBSERVATIONAL STUDY IN INDIA
por: SOLANKI, NAISARGEE, et al.
Publicado: (2021)

A REMINDER OF THE EXISTENCE OF EVALI IN THE TIME OF COVID-19
por: WASSERMAN, EVAN, et al.
Publicado: (2021)

PULMONARY CAVITATION AS A SEQUELAE OF COVID-19 PNEUMONIA: AN UNCOMMON PHENOMENON
por: REHMAN, MARIUM, et al.
Publicado: (2021)

COVID-19 PNEUMONIA IN THE SETTING OF IDIOPATHIC PULMONARY HEMOSIDEROSIS
por: KUNZE, ALLISON, et al.
Publicado: (2022)

DELAYED PRESENTATION OF CHEMICAL PNEUMONITIS AND RELATED RESEMBLANCE TO COVID-19 ASSOCIATED PNEUMONIA IN CT IMAGING: A CASE REPORT
por: ZEITOUNI, JAD, et al.
Publicado: (2022)

FOOL’S MOLD: UNUSUAL SEQUELAE OF COVID-19 INFECTION IN A YOUNG PATIENT
por: VELEZ, MATTHEW, et al.
Publicado: (2022)

PULMONARY ALVEOLAR PROTEINOSIS IN THE TIME OF COVID-19: THE RADIOLOGIC MIMICKER
por: TIPERNENI, RAGHU, et al.
Publicado: (2022)

PLEUROPARENCHYMAL FIBROELASTOSIS UNCOVERED IN A PATIENT WITH COVID-19 PRESENTING WITH PNEUMOTHORAX
por: MALIK, PARAS, et al.
Publicado: (2022)

SPONTANEOUS THORACIC FREE AIR IN COVID-19 PNEUMONIA AND CORRELATION WITH PATIENT OUTCOMES: A MULTICENTER RETROSPECTIVE ANALYSIS AND LITERATURE REVIEW
por: PATHAK, RAJAN, et al.
Publicado: (2022)

A CASE REPORT OF AMIODARONE PULMONARY TOXICITY MIMICKING AS COVID-19 PNEUMONIA
por: GREWAL, NAVJOT KAUR, et al.
Publicado: (2022)

TAKOTSUBO SYNDROME IN COVID-19 AND INFLUENZA INFECTIONS: A COMPARATIVE SYSTEMATIC REVIEW OF CLINICAL CHARACTERISTICS AND OUTCOMES
por: OLANIPEKUN, TITILOPE TO, et al.
Publicado: (2022)

A UNIQUE CASE: ACUTE EOSINOPHILIC PNEUMONIA SECONDARY TO DAPTOMYCIN: A COVID-19 PNEUMONIA MIMIC
por: MEHERN, KAITLYN, et al.
Publicado: (2022)

MISSED TB DIAGNOSIS DURING THE COVID-19 PANDEMIC: MYTH OR REAL
por: GERBINO, GABRIELLE, et al.
Publicado: (2022)

A RARE CASE OF ACUTE PULMONARY HISTOPLASMOSIS FOLLOWING COVID-19 INFECTION
por: PARKER, LYNDIE WILKINS, et al.
Publicado: (2022)

Are biologics more effective than classical disease-modifying antirheumatic drugs?
por: Nurmohamed, Michael T, et al.
Publicado: (2008)

Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2013)

Modified Banff Criteria in Assessing SARS-CoV-2-Associated Renal Pathology: An Autopsy Study
por: Popov, Hristo, et al.
Publicado: (2023)

Risk of Herpes Zoster in Individuals on Biologics, Disease-Modifying Antirheumatic Drugs, and/or Corticosteroids for Autoimmune Diseases: A Systematic Review and Meta-Analysis
por: Marra, Fawziah, et al.
Publicado: (2016)

Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region
por: Kaló, Zoltán, et al.
Publicado: (2017)

The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation
por: Góralczyk, Alicja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qquhka5muvi727oslrmpsi9cet